Getinge Interim Report July-September 2024: Strong order intake but temporary delivery disruptions had a negative impact on earnings
GOTHENBURG, Sweden, Oct. 18, 2024 /PRNewswire/ -- "The order intake increased by 10.0%, of which organic growth was 7.4%. All regions reported a positive performance," says Mattias Perjos, President & CEO at Getinge. The medtech company's net sales increased by 3.5%, of which the organic increase was 0.2%, while the operating margin weakened compared with last year. The global market...
Ping An Health Upgrades Chronic Disease Management Services with Significant Results in Digital Weight Management Program
HONG KONG and SHANGHAI, Oct. 18, 2024 /PRNewswire/ -- The Weight Management and Public Health Action Conference, hosted by the National Center for Chronic and Noncommunicable Disease Control and Prevention ("NCNCD") and its affiliated institution, the Binhai Institute for Chronic Disease Control and Prevention and Health Innovation, and co-organized by Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor", "Ping...
Antengene Announces XPOVIO® (selinexor) Approved for Its Third Indication in South Korea, Bringing Fresh Hope to Patients with MM in the Country
This approval for XPOVIO® for the treatment of patients with multiple myeloma (MM) marks the third approved indication of the drug in South Korea. To date, XPOVIO® has already been included in national health insurance or reimbursement schemes in South Korea, the mainland of China, Australia and Singapore, and is expected to...
Columbia Asia Harnesses Solar Energy for Sustainable Healthcare
Partnership with Solarvest Energy Sdn Bhd Significantly Reduces Carbon Dioxide Emissions Across Nine Hospitals in The Country KUALA LUMPUR, Malaysia, Oct. 18, 2024 /PRNewswire/ -- Columbia Asia, one of Malaysia's largest chain of private hospitals and part of Asia OneHealthcare (A1Health) has officially completed the installation of its solar panel system throughout nine hospitals across Malaysia, underscoring Columbia Asia's commitment...
OmniaBio Announces Opening of New Commercial Manufacturing Facility in Canada, Bringing Life-Saving Cell and Gene Therapies to Patients
The site will add state-of-the-art CGT capacity and employ artificial intelligence and automation to achieve critical product supply efficiencies for North American and global biotherapy clients HAMILTON, ON, Oct. 18, 2024 /PRNewswire/ -- Today OmniaBio Inc. will announce the opening of a new North American cell and gene therapy (CGT) manufacturing and artificial intelligence (AI) centre of excellence, which is...
Telix Files Form 20-F Registration Statement for Nasdaq ADS
MELBOURNE, Australia, Oct. 18, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) announces that it has publicly filed a Form 20-F registration statement (Registration Statement) with the United States (U.S.) Securities and Exchange Commission (SEC) relating to a proposed listing of American Depository Shares (ADS), representing the Company's ordinary...
Press Announcement: AIMed24 Announces Strategic Partnership with Frost & Sullivan
SAN ANTONIO, Oct. 17, 2024 /PRNewswire/ -- AIMed24, the premier event for artificial intelligence and healthcare innovation, is excited to announce its strategic partnership with Frost & Sullivan. This collaboration will further enhance AIMed24's mission to advance healthcare with cutting-edge AI technologies. The conference will take place from November 17-19, 2024, at the Caribe Royale Orlando. With over 60...
Exclusive Interview with Lang Guojun, founder of Sanyou Bio: The Key to Breaking the Bottleneck of New Drug Innovation–The Past and Future of the Super-Trillion Molecule Library
SHANGHAI, Oct. 17, 2024 /PRNewswire/ -- In the ninth year since the establishment of Sanyou Bio, Lang Guojun believes that the time is perfect to unveil the world's largest super-trillion molecule library. During the interview with Tongxieyi, he frankly and confidently expressed, "Nine years of hard work have gone to sharpen a sword, and now, the moment has come for...
Ublives Introduces SoleFlux Relax Compression Boots: The Perfect Gift for Parents to Relieve Leg Pain
NEW YORK, Oct. 17, 2024 /PRNewswire/ -- Ublives has officially launched its latest innovation: the SoleFlux Relax Compression Boots. These boots are designed to effectively relieve leg pain and discomfort. They are not only an ideal gift for parents but also a practical solution for anyone suffering from leg fatigue or circulatory issues. Ublives...
Chipscreen Biosciences’ Innovative Anti-Tumor Drug CS231295 Tablets: Investigational New Drug (IND) Application Accepted
SHENZHEN, China, Oct. 17, 2024 /PRNewswire/ -- On October 17, 2024, Shenzhen Chipscreen Biosciences Co., Ltd. (Chipscreen Biosciences, Stock Symbol: 688321.SH) submitted the company's Investigational New Drug (IND) application for CS231295 tablets, a Class 1 innovative drug for the treatment of tumors. The application has been accepted by the Center for Drug Evaluation of National Medical Products Administration of...
